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Increased translation of p27 mRNA correlates with withdrawal of cells from the cell cycle. This raised the
possibility that antimitogenic signals might mediate their effects on p27 expression by altering complexes that
formed on p27 mRNA, regulating its translation. In this report, we identify a U-rich sequence in the 5*
untranslated region (5*UTR) of p27 mRNA that is necessary for efficient translation in proliferating and
nonproliferating cells. We show that a number of factors bind to the 5*UTR in vitro in a manner dependent on
the U-rich element, and their availability in the cytosol is controlled in a growth- and cell cycle-dependent
fashion. One of these factors is HuR, a protein previously implicated in mRNA stability, transport, and
translation. Another is hnRNP C1 and C2, proteins implicated in mRNA processing and the translation of a
specific subset of mRNAs expressed in differentiated cells. In lovastatin-treated MDA468 cells, the mobility of
the associated hnRNP C1 and C2 proteins changed, and this correlated with increased p27 expression.
Together, these data suggest that the U-rich dependent RNP complex on the 5*UTR may regulate the
translation of p27 mRNA and may be a target of antimitogenic signals.
The amount of p27 is a critical determinant for the decision
of cells in G1 to either withdraw from or commit to the cell
cycle and enter S phase. p27 inhibits cyclin E-cdk2 (56). This
kinase is both necessary and rate limiting for S-phase entry (42,
43, 50) and increases threefold as G1 cells commit to DNA
replication (11, 28). Once activated in mid-G1, it triggers a
positive feedback loop, both inactivating Rb (22, 26) and pro-
moting p27 degradation (41, 55, 61), ultimately culminating in
the transition to S phase.
Small changes in the amount of p27 protein can have dra-
matic phenotypic consequences: mice heterozygous for p27
have half the wild-type amount of protein and display inter-
mediate growth phenotypes (27). Furthermore, carcinogen-
induced tumor development is similar in p27 heterozygous
mice and in animals completely lacking p27 (16). These con-
sequences can be attributed to the role of p27 as a mediator of
antimitogenic signals (7, 9, 12, 45, 59). In the absence of p27,
cells exposed to signals that induce growth arrest fail to with-
draw from the cell cycle in a timely fashion, undergoing more
mitotic divisions until other pathways mediate their withdrawal
from the cell cycle (7, 12, 59). The nature of these collaborating
or redundant pathways is not always clear; however, other cdk
inhibitors and the Rb-like protein p130 have been implicated
in fibroblasts, at least with regard to inactivation of cyclin
E-cdk2 (9).
Regardless of the potential for redundancy, the failure of
p272/2 cells to respond appropriately to growth arrest signals
leads to disease. In luteal cells, the lack of p27 leads to a
perturbation of estradiol signaling following conception and
prevents embryo implantation (59). The organization of the
ear, specifically the ability to hear, also becomes compromised
(8, 31), and p27-deficient animals develop tumors (10, 17, 27,
40, 45). Thus, an understanding of how the availability of p27
is controlled would impact our understanding of how tissue
organization occurs and how cells communicate with each
other.
p27 protein is most abundant in G1 cells and decreases
precipitously as cells enter S phase, remaining low throughout
the remainder of the cell cycle (35). The expression of p27 can
be controlled at the levels of gene transcription (29), transla-
tion (1, 23, 35), sequestration (57), nuclear localization (58),
and proteolysis (41, 44). Proteolysis of p27 is dependent on
cdk2 (41, 55, 61) and possibly skp2 (6, 50, 60), which conspire
to regulate ubiquitin-dependent proteolytic degradation of
p27, a phenomenon that might insure irreversibility of the
commitment decision, as these proteins are activated or pro-
duced just prior to or contemporaneously with the G1/S tran-
sition. A number of groups have suggested that signals pro-
moting growth arrest may act by directly interfering with p27
proteolysis; however, the cause-and-effect relationship is not
entirely clear because p27 proteolysis is dependent on proteins
and activities that occur once cells are committed to S phase.
On the other hand, growth arrest is accompanied by an
increase in the translation of p27 mRNA above a basal state
observed in asynchronous cells. In quiescent tetradecanoyl
phorbolacetate (TPA)-treated HL-60 cells, the synthesis of p27
protein is increased, correlating with an increase in the amount
of p27 mRNA associated with polysomes (35). Likewise, the
rate of p27 synthesis is increased in cells arrested in mid-G1 by
lovastatin (23). Additionally, translation of p27 mRNA contin-
ues into S phase (and presumably G2 phase), but proteolysis of
the protein prevents its accumulation (35). Thus, the transla-
tion rate of p27 mRNA can vary in a signal-dependent manner:
a basal rate in growing cells and an elevated rate (induced) in
growth-arrested cells.
The following observations prompted us to look at the trans-
lational regulation of p27 mRNA as a mechanism contributing
to growth arrest in G1 cells. First, the steady-state amount of
p27 is critical to the commitment process, and this is the sum
of the synthesis and degradation rates. Second, since proteol-
ysis is dependent on cdk2 activity and skp2, both of which
appear following commitment to the cell cycle, it would seem
that they could not effectively control p27 accumulation in the
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early G1 cell, which is deciding between proliferation and
growth arrest. However, if translation could be induced in a
cell cycle phase-dependent manner, one would expect that the
change in synthesis rate might overcome the proteolytic barrier
and p27 would accumulate. In this report, we demonstrate that
p27 mRNA translation in both basal (proliferating) and in-
duced (nonproliferating) states requires a U-rich sequence in
the 59 untranslated region (59UTR) of p27 mRNA. This se-
quence promotes polysome association of the mRNA. Two
proteins, designated p33 and p40/41, in cytosolic extracts from
asynchronous cells could be cross-linked to the 59UTR. These
factors were enriched in nocadazole-treated cells (G2/M ar-
rest) and lovastatin-treated cells (G1 arrest) compared to hy-
droxyurea-treated cells (G1/S-phase arrest). We identify p33 as
HuR, which binds to the U-rich element independently of
other proteins, and p40/41 as hnRNP C1/C2. We discuss the
cell cycle-regulated formation of these RNPs in light of the
role that translational regulation of p27 may have in the re-
sponse to antimitogenic signals.
MATERIALS AND METHODS
Cell culture and drug treatments. HeLa S3 cells were maintained in suspen-
sion culture in minimal Eagle’s medium (MEM) without Ca21 and supple-
mented with 10% enriched calf serum (Gemini). 293T cells were maintained in
Dulbecco’s modified Eagle’s medium (DME) supplemented with 4.5 g of glucose
per liter (DME HG), 2 mM glutamine, and 10% fetal bovine serum (FBS;
Gemini). MDA468 cells were grown in a 1:1 mixture of DME HG and F12 plus
nonessential amino acids supplemented with 10% FBS and 2 mM glutamine.
Nocodazole (Sigma) and hydroxyurea (Sigma) were used at 2 mM for 12 h and
2 mM for 24 h, respectively, in all cell lines. Lovastatin (Merck) was used at 30
mM for 48 h. Actinomycin D (Sigma) was used at 5 mg/ml.
Oligonucleotides. The oligonucleotides used were SSM16 (59GCTGTCCTTA
AGAGCTATGGAAGTTTTCTT39), SSM17 (59CATTCAGCGGCCGCACAG
CTCGAATTAAGAAT39), SSM23 (59GCTGTCGAATTCTCCTAGAGCTCG
GGCCGT39), T7SSM23 (59TCCTAATACGACTCACTATAGGTCCTAGAG
CTCGGGCCGT39), SSM30 (59CATTCAGGATCCCTTTCTCCCGGGTCTG
CA39), SSM31 (59GCTGTCGGATCCATGGAAGACGCCAAAAAC39),
SSM32 (59CATTCAGTATGCGGCCGCTTACAATTTGGACTTTCCGCC39),
SSM40 (59GCGGTTCCATCCTCTAGAGGAT39), SSM45 (59GGACTCAGAT
CTTCGAGAT39), SSM46 (59CATTCAGCTAGCCCGAACAAAACAAAGC
GC39), SSM47 (59CATTCAGCTAGCTGCAGACCCGGGAGAAAG39),
SSM48 (59GTATTCCGCGTACGTGATGTTCA39), SSM51 (59CAGCGCAAG
TGGAATGCCGATGCTCAGAATCACAAACCC39), SSM52 (59GGGTTTGT
GATTCTGAGCATCGGCATTCCACTTGCGCTG39), SSM53 (59GCTGTCG
GATCCATGTCAAACGTGCGAGTG39), and SSM55 (59CATTCAGTATGC
GGCCGCTCAGTGGTGGTGGTGGTG39).
The sequence of the 42-nucleotide transcript and RNA from Curachem in-
cludes nucleotides 77 to 118, as indicated in Fig. 3.
The irrelevant scrambled oligonucleotide was 59UGAUCUUGACAAUUGG
CGUAAUCCAGAAGCGCAGUCAGGUUUGAAUUCAUUUGAA39.
The 165-nucleotide gamma globin transcript used in Fig. 5C was derived from
pSP65Hg (a gift from Henry Furneaux) linearized with Sau3AI. It contains 80
nucleotides of coding sequence and 85 nucleotides of 39UTR.
Isolation of human p27 5*UTR. Primers SSM23 and SSM30 were used to
amplify sequences containing the 59UTR from a genomic clone isolated from an
EMBL3 SP6/T7 genomic library (Clontech). This PCR product was then cloned
into the green fluorescent protein (GFP) and luciferase expression vectors as
described below and sequenced using primers SSM40, SSM45, and SSM48 and
GL primer 2 (Promega).
Antibodies. Western blotting was performed as described (57). The affinity-
purified anti-p27 antibody has been described (57). The 19F12 anti-HuR mono-
clonal antibody has been described (H. Furneaux, submitted for publication).
Antibodies to cdk2 (M2; Santa Cruz Biotechnology), a-tubulin (T9026; Sigma),
and b-galactosidase (Z378A; Promega) are commercially available.
Isolation of nuclear and cytoplasmic RNA and protein. Nuclear and cytoplas-
mic RNA was obtained as described (53). Nuclear and cytoplasmic protein
extracts were prepared as described (62).
Construction of p27ck reporters. The cyclin binding domain mutant of human
p27 PV3KK (32) was further mutated by site-directed mutagenesis using SSM51
and SSM52 with the Quickchange system (Stratagene). This generated an
FDF3ADA mutation in the cdk binding domain. The p27ck2 mutant was then
amplified by PCR using primers SSM53 and SSM55 and directionally cloned into
BamHI- and NotI-digested pSVL vectors. All clones were confirmed by direct
sequencing.
Construction of luciferase reporters. The reporters were generated by sub-
cloning the simian virus 40 (SV40) promoter (nucleotides 22 to 239) from the
pGL-2 promoter (Promega) directly into the XhoI and HindIII sites of pEGFP-1
(Clontech) to create pSVG. The p27 59UTR was amplified from a human
genomic clone by PCR using primers SSM23 and SSM30. The p27 39UTR was
amplified from pBD59 p27 with primers SSM16 and SSM17. These products were
directionally cloned into pSVG. GFP sequences in the pSVG series were re-
placed with a luciferase PCR product using primers SSM31 and SSM32 and the
pGL2 promoter vector. This created the pSVL series of constructs. To generate
clones with an SV40 polyadenylation signal, an XhoI-NotI-digested pEGFP-1
vector was ligated to and XhoI-AflII-digested pSVL insert.
Deletion of the U-rich element of the 59UTR was performed by PCR using
p59SVL and primers SSM45, SSM46, SSM47, and SSM48, which replaced the
U-rich element with an NheI site.
Transfection assay. For the transfection of HeLa cells, we combined 8 3 106
cells with 10 mg of pSVL construct, 5 mg of pCMV-b, and 5 mg of pCDNA3
(Invitrogen) in a final volume of 800 ml in a 0.4-cm cuvette. Cells were electro-
porated at 0.28 kV and 960 mF using a Bio-Rad electroporator and then plated
for 24 h before harvesting. 293T and MDA468 cells were transfected using
CaPO4 (Gibco-BRL) according to the manufacturer’s instructions. 293T cells
were harvested 24 h after the CaPO4 precipitate was washed off, and MDA468
were used 48 h afterwards.
RNase protection assay. To generate a luciferase probe for the RNase pro-
tection assay, we subcloned a BamHI-NotI PCR product from pGL-2 promoter
into pBluescript II (Clontech). This clone (pB-LUC) was digested with PacI and
transcribed with T7 RNA polymerase (Gibco-BRL), resulting in a 375-nucleo-
tide antisense probe. For b-galactosidase, we subcloned an AccI-NdeI (blunt)
fragment of pCMV-b (Clontech) to AccI- and SmaI-digested pBluescript II. This
clone (pB-bAcc-Nde) was digested with AccI and transcribed with T7 RNA
polymerase, resulting in a 249-nucleotide antisense transcript. The sizes of the
protected luciferase and b-galactosidase transcripts detected in RNA from trans-
fected cells were 325 and 193 nucleotides, respectively. RNase protection was
performed as described (51).
Endogenous c-myc transcripts were detected using mouse pTri c-myc/exon 3
(Ambion). The human and mouse exon 3 sequences diverge at two nucleotides
and thus yielded three protected fragments.
Polysome gradients. Continuous sucrose gradients (10 ml, 15 to 40%) were
prepared and run as described previously (35), except for the following modifi-
cations. Each 1-ml fraction was collected directly into 120 ml of 8.3% sodium
dodecyl sulfate (SDS) and 83 mM EDTA. Then 200 mg of proteinase K was
added, and samples were incubated at 37°C for 15 min and extracted with
phenol-chloroform.
EMSA and UV cross-linking assay. For the electrophoretic mobility shift assay
(EMSA), 59UTR RNA transcripts were prepared by PCR amplification of the
appropriate pSVL template using T7SSM23 and SSM30 and transcribed using
T7 RNA polymerase. Radiolabeled probes and glutathione S-transferase (GST)-
FIG. 1. 59UTR of p27 mRNA contains sequences that enhance expression of heterologous reporters. (A) Sequence of the coding stand of p27 mRNA. 39UTR
sequence was obtained by identifying and sequencing expressed sequence tags with homology to the p27 ORF (AA206936, R18972, and AA180937). To determine the
59UTR sequence, we combined analysis of 59RACE using HL-60 mRNA as the template and sequences obtained from a human genomic clone. Nucleotide differences
between the 59UTR sequence and that reported by Minami and colleagues (36) are indicated below the sequence. The initiation and termination codons are underlined.
(B) The 59UTR is required to overcome suppressive effects of the 39UTR on p27 accumulation. 293T cells were transfected with 10 mg of an expression vector encoding
a noncyclin/cdk binding form of p27 (p27ck2), with different combinations of p27 UTRs as defined above each lane. Then 5 mg of a plasmid expressing the
b-galactosidase gene (b-gal) from the cytomegalovirus promoter was cotransfected. Transfection conditions and protein extraction are described in the text. Following
extraction, lysates were normalized for b-galactosidase activity, and equivalent units were resolved by SDS-PAGE and Western blotted with anti-b-galactosidase
antibodies (bgal) or anti-p27 antibodies as indicated to the right. (C) The effect of the UTRs is independent of sequences within the ORF. Experimentally similar to
panel B, but luciferase replaced the p27ck2 ORF in the expression vector and we used HeLa cells. The UTRs used are shown below each bar, and the accumulation
of luciferase normalized for b-galactosidase is shown on the y axis. This experiment was repeated greater than five times with similar results, and a representative
experiment is shown. (D) The presence of the p27 UTR sequences did not affect the yield of mRNA. The data in this panel are matched to the transfection shown
in panel C. We determined the amount of luciferase (luc) and b-galactosidase (b-gal) mRNA by RNase protection assay in 10 mg of cytosolic HeLa mRNA. The
protected luciferase (325 nucleotides) and b-galactosidase (193 nucleotides) transcripts are indicated with arrows. The mobilities of the unprotected probes are shown
in the rightmost lane. We used 10 mg of tRNA as a negative control.
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FIG. 2. 59UTR of p27 mRNA contains a sequence that enhanced translation of the mRNAs that encode it. (A) RNA localization. Luciferase expression vectors
flanked by the 59 and 39 UTRs or the 39UTR alone were cotransfected into HeLa cells with a b-galactosidase expression vector as described in the legend to Fig. 1.
Cytosolic (C) and nuclear (N) RNAs were isolated as described in the text, and the amount of luciferase and b-galactosidase mRNA in 10 mg was determined by the
RNase protection assay. Below each sample we indicate the source of the RNA and the probe used: cytosol (C) or nuclear (N), with the 59 and 39 UTRs (59 1 39) or
39UTR alone (39). Quantitation was done on a phosphorimager using MacBas software. Representative data are shown; the experiment was repeated twice with two
different extraction conditions. (B) RNA half-life. HeLa cells were transfected as in panel A and treated with actinomycin D (5 mg/ml) for the times indicated (minutes)
above each lane prior to extraction of cytosolic mRNA. The UTR-containing construct used is indicated above each set of samples. As a control for the actinomycin
treatment, a similar analysis of the endogenous c-myc mRNA level in cells transfected with the 59 and 39 expression constructs is shown. (C) Polysome association. As
in panel A, 293T or HeLa cells were cotransfected with the luciferase expression vector flanked by either the 59 and 39 UTRs or the 39UTR alone with another plasmid
expressing b-galactosidase. Following this, the cells were divided into two populations, with one receiving puromycin (150 mg/ml) for an additional 30 min. Cytosolic
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HuR were prepared as described (24). The specific activity of each probe was 1 3
104 to 5 3 104 cpm/pmol.
Binding reactions using extracts as a source of protein were performed in a
20-ml volume containing 20 fmol of transcript, 15 mg of protein extract, 50 mg of
tRNA, 50 mM Tris (pH 7.0), and 5 mg of bovine serum albumin. Reactions were
performed essentially as described (24).
For UV cross-linking experiments, following the incubation the binding reac-
tion was irradiated at 1,200 mJ/cm2 in a Stratalinker (Stratagene). RNase A
(Sigma) and RNase T1 (Calbiotech) were then added to 500 mg/ml and 250 U/ml,
respectively, and incubated at 30°C for 15 min prior to SDS-polyacrylamide gel
electrophoresis (PAGE).
Purification of hnRNP C1/C2. HeLa nuclear extract (60 mg) was loaded onto
a 5-ml HiTrap Q-Sepharose column and eluted with a 0.25 to 0.5 M linear KCl
gradient. p40/41 activity eluted after the major protein peak at 0.4 M KCl. Pooled
fractions from the Q column were loaded on a 1-ml methyl-Sepharose column
and eluted with a linear gradient of 1 to 0 M (NH4)2SO4. p40/41 activity eluted
at 0.45 M (NH4)2SO4. These fractions were pooled, loaded on a 1-ml HiTrap
SP-Sepharose column, and eluted with a 0.05 to 1 M KCl gradient; the peak
activity eluted at 0.45 M KCl. The Coomassie-stained p40 and p41 bands were
excised for analysis by mass spectrometry fingerprinting (13).
RESULTS
A U-rich element in the 5*UTR of p27 mRNA facilitates
polysome association. To better understand the translational
regulation of p27 and the role it plays during the cell cycle and
growth arrest, we needed to first isolate the 59 and 39 UTRs of
human p27. We obtained the 39UTR sequence by defining a
contig in the GenBank dbest database and sequenced overlap-
ping clones on both strands (Fig. 1A). We obtained 59UTR
sequence by sequencing a genomic clone encoding the p27
locus (unpublished data). This sequence largely agreed with
that published by Minami and colleagues (36); the only excep-
tions (indicated in Fig. 1A) are a T-to-C change and the ab-
sence of a G nucleotide at positions 37 and 66/67, respectively.
These differences could be due to polymorphisms or sequenc-
ing errors. We reasoned that cis-acting regulatory sequences
might be in either the 59UTR, the 39UTR, or the open reading
frame (ORF) or any combination of these elements.
To investigate which of these elements controlled transla-
tion, we subcloned the entire p27 cDNA or versions lacking
either the 59 or 39 UTR into a vector containing the SV40 early
promoter and polyadenylation signal. To prevent expression of
p27 from altering the distribution of cells in the cell cycle but
maintaining the presumptive secondary structure of the full-
length mRNA, we mutated 10 nucleotides encoding four
amino acids required for cyclin-cdk binding and inhibition
(p27ck2) (61). Transfection of 293T cells with these constructs
did not lead to an alteration in cell cycle distribution (data not
shown). Cells were cotransfected with a b-galactosidase ex-
pression vector to allow for normalization of p27 expression,
and we examined the accumulation of p27 by immunoblotting
(Fig. 1B). Expression of protein from a construct containing
both the 59 and 39 UTRs was nearly equivalent to that observed
in the control construct without any additional UTR se-
quences. From this point, we use the phrase no UTR to rep-
resent the basal construct which contains the UTR sequences
provided by the expression vector but not additional p27
mRNA sequences. However, expression of p27ck2 was greatly
diminished when the 39UTR was present alone, and the
59UTR alone could promote expression. Thus, the 59UTR can
suppress or overcome the negative effect of the 39UTR on
accumulation of p27ck2. This suggests that there is a positive
regulatory element in the 59UTR. To determine if the UTR-
dependent effects required sequences in the ORF, we replaced
the p27 coding sequence with luciferase and repeated the anal-
ysis. Similar UTR-dependent changes in luciferase expression
were detected when normalized for b-galactosidase. The
59UTR was able to increase luciferase expression 2- to 3-fold,
whereas the 39UTR inhibited luciferase expression more than
10-fold. When both UTRs were present on the luciferase re-
porter, the 59UTR was able to suppress many of the negative
effects of the 39UTR (Fig. 1C). The yield of each transcript as
measured by RNase protection was equivalent in all samples,
suggesting that the activity measurements do not reflect differ-
ences in steady-state mRNA levels (Fig. 1C). This eliminated
the possibility that the sequences within the p27 ORF contrib-
uted to the UTR-dependent effects.
The steady-state amount of protein can be affected by a
number of factors: the rate of mRNA synthesis and export
from the nucleus, the stability of the mRNA in the cytosol, and
the incorporation of the mRNA into polysomes. To determine
how the 59UTR sequences affected the accumulation and uti-
lization of luciferase mRNA, we examined the amount of
mRNA in the cytosol, the half-life of cytosolic mRNA, and the
association of the mRNA in polysomes using the 59-plus-39
UTR construct and the 39UTR construct alone (Fig. 2). When
normalized for the amount of cotransfected b-galactosidase
mRNA, the amount of mRNA in the cytosol of transfected
cells was equivalent for the two constructs (Fig. 2A), suggesting
that the accumulation of mRNA in the cytosol was not affected
in a UTR-dependent manner. We also did not observe any
significant UTR-dependent changes in the half-life of these
messages in the presence of actinomycin D. Endogenous c-myc
mRNA had a half-life of approximately 40 min in the same
samples, confirming that the drug treatment was effective (Fig.
2B). Actinomycin D incubations as long as 12 h were also
performed and revealed no UTR-specific differences in mRNA
half-life (data not shown). Thus, the accumulation of luciferase
as controlled by the 59 and 39 UTRs was likely due to transla-
tional affects.
To further establish this point, we fractionated cytosolic
extracts from transfected cells on continuous sucrose gradients
and monitored absorbance at 254 nm to follow RNP complexes
(Fig. 2C). To specifically identify the region of the gradient
containing polysomes, we treated parallel cultures with puro-
mycin and fractionated the RNA. Puromycin causes mRNA to
accumulate in the monosome and subunit fractions of the
gradient (Fig. 2C). Simply comparing the amount of puromy-
cin-sensitive material in each fraction, it was clear that the
luciferase mRNAs containing both the 59 and 39 UTRs were
enriched in the heavier regions of the gradient compared to the
luciferase mRNAs containing the 39UTR alone. The distribu-
tion of cotransfected b-galactosidase mRNA, however, was not
significantly different between these two populations of cells
(Fig. 2C). This firmly established that the 59UTR contained
sequences that facilitated polysome association in cycling cells.
Next, we wanted to identify sequences in the 59UTR that
were responsible for this positive effect and determine if they
interact with proteins in a cell cycle phase-specific manner.
RNA was prepared as described (35) and fractionated on continuous sucrose gradients. Fractions (1 ml) were collected (numbered below each recording), and their
absorbance at 254 nm was determined during collection. Mock-treated samples are indicated by the solid line and puromycin (puro)-treated samples by the dotted line.
The migration of free mRNA, 40S, and 60S are indicated. Half of each fraction was subsequently used as a source of RNA for the RNase protection assay as described
in the legend to Fig. 1. Each panel contains the data from a single experiment using either the 59 and 39 UTRs or the 39UTR alone. In the table we indicate the amount
of mRNA in polysomal (puromycin sensitive), monosome or subunit associated, and free RNA as a percent of the total. Two representative transfections in two different
cell lines are shown.
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Sequence comparisons of the 59UTR from mouse, human, and
rat (Fig. 3A) showed the presence of a highly conserved U-rich
element. Other conserved regions, notably those between this
element and the initiating methionine, were noted as well.
Inspection of the secondary structure of the 59UTR (Fig. 3B)
revealed that the U-rich element could form into a loop sur-
rounded by a stable stem structure. Similar stem-loop struc-
tures have been implicated in the regulation of translation
initiation in ferritin and other mRNAs (37, 38, 52). To test the
significance of the U-rich loop, we deleted the nucleotides that
FIG. 3. U-rich element required for the positive influence of the 59UTR. (A) Homology between the sequences of the mouse, rat, and human p27 59UTRs.
Sequences were aligned from the ATG sequence encoding the initiating methionine at the end. Identical nucleotides in two of the three sequences are indicated in
black boxes. Sequences deleted by the DU mutation are underlined. (B) Structural folding model of the 59UTR. Using the mFOLD program (34), a predicted structure
of the 59UTR was made. (C) The U-rich sequence is necessary for 59UTR function. HeLa cells were transfected as described in the legend to Fig. 1 using the constructs
listed below each bar. Accumulation was normalized to that of the parental luciferase construct lacking p27 UTR sequences (set at 100%). The mean and standard
deviations from three independent experiments are indicated.
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comprise the loop and a number of additional nucleotides at
the 39 end (underlined in Fig. 3A). The removal of the 39 stem
nucleotides was done to ensure complete disruption of the
stem-loop structure. In constructs either containing or lacking
the 39UTR, deletion of the 59UTR U-rich element reduced
luciferase expression, even below that observed in the parental
vector (Fig. 3C). In all cases, the amount of mRNA and the
half-life of the mRNA were not significantly affected (data not
shown). This indicated that the U-rich element was required
for effective translation of this message, and in its absence
either the sequence of the 59UTR or the structure formed by
it was capable of inhibiting translation. From these studies we
concluded that the 59UTR contained a U-rich element that
participated in the incorporation of p27 mRNA into polysomes
in cycling cells.
5*UTR binds complexes in a cell cycle phase-dependent
manner. Having defined a role for the 59UTR in translation of
p27 mRNA and noting that the U-rich element participated,
we next wanted to determine if we could identify proteins that
would interact with the 59UTR in a U-rich element-dependent
manner. We used an RNA EMSA to determine whether pro-
tein complexes could form on the 59UTR. We made cytosolic
extract from asynchronous cultures of 293T cells and incubated
them with a uniformly labeled 59UTR transcript in the pres-
ence of a 100,000-fold molar excess of nonspecific tRNA. A
slower-migrating complex was detected in asynchronous ex-
tracts (Fig. 4A). Under the conditions used, approximately
50% of the RNA remains free (when binding is maximal, i.e.,
with the G2-M extract), as determined by EMSA (Fig. 4A). As
expected, increasing the amount of protein increased the
FIG. 4. RNP complexes form on the 59UTR in a cell cycle phase-specific manner dependent on the U-rich element. (A) An RNP complex forms on the 59UTR
of p27 mRNA. Cytosolic extract was prepared from asynchronously exponentially growing 293T cells (Expo), cells treated with 2 mM hydroxyurea (G1/S), and cells
treated with 2 mM nocadazole (G2/M), and 15 mg of extract was combined with 20 fmol of uniformly labeled 59UTR transcript, and free and bound probe were separated
by electrophoresis through native 1% agarose gels before autoradiography. The cytosolic G2/M extract contained the greatest amount of binding activity. (B) Effective
competition for the 59UTR binding species required the U-rich element. Similar to panel A, but during the incubation of the G2/M cytosolic extract with probe, we
added either the 59UTR or a 59UTR lacking the U-rich element (DU) as an unlabeled competitor. The molar excess of competitor to transcript is indicated above each
lane. The first lane on the left shows the migration of probe without any extract added. The second lane shows the probe with G2/M cytosolic extract and no competitor.
(C) p33 and p40/41 can be UV cross-linked to the 59UTR and are enriched in cytosolic extract obtained from G2/M-phase cells. Following the treatments in panel A,
nuclei and cytosol were separated, and extracts prepared for binding to the uniformly labeled 59UTR transcript. Subsequently, the reaction products were cross-linked
by UV as described in the text and RNA degraded, and the resulting products were resolved by SDS-PAGE and detected by autoradiography. Only the products marked
with asterisks were specifically cross-linked by UV. The other bands were extract dependent but not UV dependent (for example, see Fig. 4D and 5B). It is clear that
both nuclear and cytosolic proteins can be cross-linked; however, the amount of the proteins is increased in the extract prepared from G2/M-enriched cells. (D) p33
and p40/41 binding require the U-rich element. As in panel C, the G2/M extract was incubated with uniformly labeled probe; however, the middle two lanes included
a 500-fold molar excess of either unlabeled competitor 59UTR or 59UTR lacking the U-rich element (DU). Furthermore, using a uniformly labeled 59UTR lacking the
U-rich element, we were unable to detect any specific binding proteins (last two lanes on the right). Probes are indicated below the autoradiograph. UV treatment is
indicated below each lane. Competitors are shown above the appropriate lanes. Molecular size markers are shown on the left.
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amount of RNA bound, but the specificity of interaction was
compromised at higher ratios of protein to transcript (data not
shown).
We next asked if this binding activity was enriched at par-
ticular stages of the cell cycle. To accomplish this, we prepared
cytosolic extracts from hydroxyurea-treated or nocadazole-
treated cells. These treatments lead to accumulation of cells in
G1/S phase and in late G2/M phase, respectively. Incubation of
these extracts with the 59UTR transcript and resolution of
bound and free RNA by agarose gel electrophoresis demon-
strated that a complex was enriched in the extract derived from
nocadazole-treated cells (Fig. 4A). This complex could be com-
peted by a 100-fold molar excess of unlabeled 59UTR RNA but
not by a 1,000-fold molar excess of a similar competitor lacking
the U-rich element (Fig. 4B).
To determine the molecular weight of the protein(s) directly
contacting the 59UTR, we performed UV cross-linking exper-
iments. We prepared nuclear and cytosolic extract from the
hydroxyurea- and nocadazole-treated cells, subjected the bind-
ing reactions to UV, and digested the RNA before resolution
of the labeled proteins on SDS-PAGE. Three cross-linked
species, a doublet migrating at 40/41 kDa and a 33-kDa pro-
tein, were enriched in the cytosolic extract prepared from late
G2/M cells compared to S-phase cells. Similar proteins were at
least equally abundant or more abundant in the nuclear ex-
tracts (Fig. 4C). In extracts from S-phase cells, p40/41 and p33
were largely nuclear, and there was very little cytosolic protein.
In cytosolic extracts from asynchronous cells, all three species
could be detected (data not shown). Importantly, the cross-
linking of these proteins to the 59UTR was dependent on the
U-rich element (Fig. 4D). These interactions could be com-
peted with by a 500-fold molar excess of unlabeled competitor
containing the U-rich element but not by the unlabeled tran-
script lacking this element (Fig. 4D). Consequently, from these
data we concluded that a 59UTR U-rich element-dependent
binding activity could be detected in the cytosol of G2/M cells.
It was not clear from these studies if these proteins bound to
the same or different RNAs.
p33 protein is HuR. We next wanted to identify the proteins
that interacted with the U-rich element. Members of the
ELAV family of RNA binding proteins were candidates for a
number of reasons. The size of the cross-linked species was
similar to the reported 36-kDa size of HuR. There is evidence
that the localization of HuR changes during the cell cycle,
becoming more cytosolic in G2 cells (Fig. 5A) (3), and that
HuR can shuttle between the nucleus and cytosol (14, 15, 46).
In addition, HuR has been implicated in regulating mRNA
stability and transport (18, 25, 30, 33, 39, 46) as well as trans-
lation (2).
To determine if HuR was binding to the 59UTR, we at-
tempted to immunoprecipitate proteins cross-linked to the
59UTR in late G2/M cytosolic extract. Using a monoclonal
antibody raised against HuR (Furneaux, submitted), we were
able to immunoprecipitate the p33 species, which was not
precipitated with an unrelated isotype-matched antibody
raised against TrpE (Fig. 5B).
We next asked if the binding of HuR to the p27 59UTR was
dependent on other factors in the G2/M extract, i.e., p40/41.
Purified recombinant HuR was incubated with labeled tran-
script and assayed for complex formation. GST-HuR bound to
the p27 59UTR and not a control g-globin transcript, whereas
GST did not (Fig. 5C). Using deletion analysis and binding
assays, we identified a 42-nucleotide region overlapping the
U-rich element which was required for HuR binding (Fig. 5D,
and unpublished data). An RNA encoding this 42-nucleotide
region effectively competed for HuR binding, whereas an ir-
relevant oligoribonucleotide of similar base composition did
not (Fig. 5E). This indicated that HuR alone could bind to the
U-rich sequences in the 59UTR of p27. Together these data
indicate that the 33-kDa species associated with the p27
mRNA in a G2/M-phase-specific manner is HuR. Further-
more, HuR binding to the 59UTR site is not dependent on
other factors present in the cell extract. To our knowledge, this
is the first time a binding site for a mammalian ELAV protein
has been defined in the 59UTR of an mRNA.
p40/41 is hnRNP C1/C2. To identify the p40/41 binding
activity, we used ion-exchange chromatography and the UV
cross-linking assay described above to purify these proteins.
After determining the linear range of the assay, we defined 1
unit as 200 counts of cross-linking activity on a phosphorim-
ager screen.
We were able to detect p40/41 binding activity in the cyto-
plasm of nocadozole-treated cells, but using EMSA and cross-
linking we found that a 1 M NaCl extraction of HeLa nuclei
had the highest specific activity (data not shown). Therefore,
we used this as the starting material for purification. Prelimi-
nary binding studies suggested that p40/41 could be absorbed
to and eluted from Q, methyl, and SP matrices; thus, we used
these three columns to purify p40/41 binding activity from 60
mg of HeLa nuclear extract (Fig. 6A). This purification scheme
resulted in a 141-fold purification of p40/41 (Fig. 6B). The SP
fractions were run on SDS-PAGE gels and stained with silver
(Fig. 6A) and Coomassie. A doublet migrating at 40 kDa
cofractionated with p40/41 59UTR binding activity. The Coo-
massie-stained p40 and p41 bands were excised for analysis by
mass spectrometry fingerprinting (13).
Peptide mass fingerprinting of p40 and p41 positively iden-
tified them as hnRNP C1 and C2, a pair of previously described
RNA binding proteins. hnRNP C1 and C2 are alternatively
spliced products of the same gene and differ by 13 amino acids
near the middle of the protein (5). These two proteins migrate
as a doublet on SDS-PAGE gels, with C2 migrating more
slowly than C1 (47). Monoclonal antibodies raised against
hnRNP C1/C2 (47) are able to immunoprecipitate the p27
59UTR p40/41 binding activity from HeLa nuclear extract,
whereas a monoclonal against bacterial TrpE cannot (Fig. 6C).
We conclude that the p40/41 binding activity consists of the
hnRNP C1/C2 proteins.
hnRNP C1 and C2 are nuclear proteins proposed to be
involved in mRNA processing (48). They bind to U-rich se-
quences on mRNA with high affinity (21). Recent work has
suggested that there may be a cytoplasmic role for these pro-
teins in the cytoplasm of differentiated cells bound to transla-
tionally induced platelet-derived growth factor (PDGF)
mRNA (54). It is therefore possible that the C proteins could
regulate translation when they are in the cytoplasm.
Translation and formation of RNP complexes in growth-
arrested cells. Having established above that RNP complexes
containing HuR and/or hnRNP C1/C2 would form on the
59UTR, we next wanted to determine if these proteins were
cytosolic and accessible to the p27 mRNA in cells where trans-
lation of p27 mRNA is enhanced. We and others had previ-
ously shown that the rate of p27 synthesis was increased in
growth-arrested cells compared to asynchronous populations
or cells in S phase (1, 23, 35). Using MDA468 cells, we ob-
served lovastatin-induced accumulation of G1 cells and a re-
duction in S-phase cells, correlating with accumulation of p27
(Fig. 7A and B). this increase could be due to both suppression
of proteolysis (49) and increased translation (23). To focus on
the translational control mechanism, we first examined the
expression of luciferase from the UTR-dependent reporters.
Lovastatin enhanced expression from the 59UTR in a manner
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FIG. 5. p33 is the ELAV protein HuR. (A) HuR is enriched in the cytosol of G2/M cells compared to S-phase or exponentially growing cells. Nuclear (N) and
cytosolic (C) extracts were prepared from asynchronous exponentially growing 293T cells (Expo), cells treated with hydroxyurea (G1/S), and cells treated with
nocadazole (G2/M), and 80 mg of each extract was resolved by SDS-PAGE, transferred to a polyvinylidene fluoride membrane, and blotted with antibodies raised
against alpha-tubulin or HuR as indicated to the right of each panel. Molecular size markers are indicated on the left. The source of each extract is indicated above
the panels. (B) HuR in the cytosol of G2/M cells binds to the 59UTR. For immunoprecipitation, the cross-linking was done as described in the legend to Fig. 4C but
the amounts were scaled up fivefold. One sample was not incubated with an antibody; the others were incubated with either the 19F12 monoclonal antibody to HuR
or a monoclonal antibody raised against bacterial TrpE protein, as indicated above each lane. (C) Purified HuR binds to the 59UTR of p27 mRNA. Increasing amounts
of recombinant GST-HuR were purified from bacterial cultures and incubated with uniformly labeled 59UTR RNA or a size-matched sequence of 165 nucleotides from
the gamma globin mRNA. The amount of GST or GST-HuR in each binding reaction is shown below each lane. The migration of the free and bound probe (arrow)
is indicated to the right of the autoradiograph. (D) The U-rich element is necessary for HuR binding. Mutants in the 59UTR were generated by standard PCR cloning
procedures and served as templates for the production transcripts to assess the binding of purified GST-HuR and p33. A schematic of the 59 deletion series is shown,
and each mutant is numbered as in Fig. 3A. The ability of a mutant transcript to bind the recombinant proteins and cross-link to p33 in G2/M extracts is indicated.
Binding reactions were performed with GST-HuR or GST alone. Binding activity is scored as positive or negative. ND, not done. Under these conditions we could not
detect GST binding to the transcripts. The superscript a denotes the transcript commonly used as DU in this work, and b denotes the sequence of the 42-nucleotide
(nt) competitor used in panel E. (E) The U-rich element is sufficient to compete with HuR binding to the 59UTR probe. As described in the legend to Fig. 4C, uniformly
labeled 59UTR transcript was incubated with 50 nM GST-HuR in the presence or absence of increasing amounts of a 42-nucleotide RNA containing the U-rich element
or a scrambled oligoribonucleotide (Curachem; sequence indicated in the text). The products of the binding reaction were resolved by EMSA. The competitor used
and the fold relative to the labeled transcript are indicated above each lane. The presence or absence of GST-HuR is indicated below each lane. The migration of the
free probe and the bound probe (arrow) is indicated on the right of the autoradiograph.
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dependent on the U-rich element, indicating that this element
was required for expression in growth-arrested cells (Fig. 7C).
Lovastatin treatment did not affect the steady-state levels of
mRNA (data not shown). A faster-migrating form of p40/41
could be cross-linked to the 59UTR in the extract from lovas-
tatin-treated cells (Fig. 7D). We were able to immunoprecipi-
tate this complex with antibodies specific to hnRNP C1/C2
(Fig. 7E), suggesting that this mobility shift is due to modifi-
cation of hnRNP C1/C2. We suspect that the differences in the
mobility of hnRNP C1/C2 in nocadazole- and lovastatin-
treated cells could be due to phosphorylation (47). On longer
exposures, HuR was also detected (data not shown).
DISCUSSION
Since its first description by three independent groups in late
1996 and early 1997, remarkably little attention has been paid
to the translational regulation of p27. This is surprising since
this mode of regulation corresponds best with the role of p27
in growth arrest. In lovastatin-treated cells (23), confluence-
arrested BALB/c 3T3 cells (1), and TPA-treated HL-60 cells
(35), the accumulation of p27 was attributed to changes in the
rate of synthesis, not to changes in the rate of degradation.
From studies of PDGF-induced cell cycle reentry of BALB/c
3T3 cells, it appeared that translation was inhibited as cells
acquired competence to enter the cell cycle, but that the fur-
ther reduction in p27 as cells entered S phase was due to
proteolysis. This was consistent with the findings in HL-60
cells: there was an increase in the amount of p27 mRNA
associated with polysomes in G0 cells compared to G1 cells.
The rate of p27 proteolysis was the same in G0 and G1 cells but
increased as cells entered S phase.
Three major conclusions can be drawn from this work. First,
the U-rich element located in the 59UTR of p27 mRNA is
necessary in both cycling and noncycling cells for efficient
translation. Second, this element interacts with HuR and
hnRNP C1/C2 in a cell cycle phase-specific manner. Third, an
induction of modified hnRNP C1/C2 complexes on the 59UTR
correlates with an induction of p27 translation.
The U-rich element in the 59UTR of p27 provides a high-
affinity binding site for HuR (Kd, ;10 nM; data not shown).
This is the first report of a mammalian ELAV protein binding
FIG. 6. p40/41 is hnRNP C1/C2. (A and B) Purification of the p40/41 binding activity. The purification procedure and silver-stained gel monitoring purification are
shown. 59UTR binding activity was measured by UV cross-linking of eluted fractions as described in the legend to Fig. 4C. To obtain sequence from the p40/41 species,
the final fraction of the SP column was resolved by preparative SDS-PAGE; the region was excised and subjected to tryptic digestion, and the products were analyzed
by mass spectroscopy. The purification table is shown. Sizes are shown in kilodaltons. (C) hnRNP C1/C2 binds to the 59UTR. Cross-linking and immunoprecipitation
were done as described in the legend to Fig. 5B using the monoclonal antibody to C1/C2 (4F4) in place of HuR. The products in the precipitate and the supernatant
were resolved by SDS-PAGE. Following immunoprecipitation with 4F4, p40/41 is enriched in the immunoprecipitate and appropriately diminished in the supernatant.
Its migration is indicated to the right of the autoradiogram. The pellet and supernatant from the immunoprecipitation are indicated above each lane.
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to the 59UTR of an mRNA; however, similar interactions have
been observed in lower metazoans. In Drosophila melanogaster,
sex-lethal (sxl), another ELAV family member, binds to the
59UTR of the male-specific lethal (msl2) transcript in female
flies (4). In this system, sxl negatively regulates translation of
the msl2 transcript (4, 19). In mammalian cells, HuR has been
implicated in regulating mRNA stability through 39UTR AU-
rich sequences (46). Antic and colleagues have also shown that
Hel-N1, a neuron-specific ELAV family member, regulates
translation of neurofilament M mRNA, presumably through a
FIG. 7. Lovastatin treatment induces changes in the accumulation of p27 and the migration of hnRNP C1/C2. (A) Flow cytometry. MDA468 cells were treated with
either lovastatin, hydroxyurea, or nocadazole as described in the text, and the cell cycle position was determined by propidium iodide staining and flow cytometry as
described (57). Below each DNA histogram we have labeled the G1 and G2 peaks as 1C and 2C, respectively. Each treatment is indicated to the left of the DNA content
profile. (B) Lovastatin treatment induces accumulation of p27 protein. Following treatment of MDA468 cells with either lovastatin (1LOV) or solvent controls
(2LOV), protein extracts were prepared and increasing amounts were resolved by SDS-PAGE and transferred to polyvinylidene fluoride, and the amount of p27
determined by immunoblot with enhanced chemiluminescence as a detection reagent. The amount of extract loaded is indicated above each lane (in micrograms). (C)
Lovastatin treatment increases translation of the templates containing the 59 and 39 UTRs of p27 mRNA in a U-rich element-dependent manner. At 24 h following
cotransfection of MDA468 cells with 10 mg of luciferase reporter constructs flanked by the indicated UTRs and 5 mg of CMV-b-galactosidase, the cells were exposed
to 30 mM lovastatin or solvent vehicle (1LOV and 2LOV, respectively), and activity was measured 48 h later as described in the legend to Fig. 3C. To account for
any affect of lovastatin on general cell metabolism, all the data were normalized to the expression of the constructs containing only the vector UTRs. (D) A p40/41
binding activity can be detected in the cytosol of lovastatin-treated cells. Cytosolic extract was prepared from the treated and control cells in panel A, and following
a binding reaction to a uniformly labeled 59UTR transcript, associated proteins were detected by UV cross-linking as described in the legend to Fig. 4C. (E) The p40/41
binding protein in lovastatin-treated cells is hnRNP C1/C2. After scaling up the binding reactions fivefold, following cross-linking and RNA digestion, immunopre-
cipitation was done as described in the legend to Fig. 5B, using the monoclonal antibody to either C1/C2 (4F4) or TrpE, as indicated above each lane. The products
in the precipitate and in the supernatant were resolved by SDS-PAGE, and p40/41 was enriched in the immunoprecipitate and appropriately diminished in the
supernatant. Its migration is indicated to the right of the autoradiogram. The pellet and supernatant (SN) from the precipitation are indicated above each lane.
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39UTR binding site (2). These data together suggest that cy-
toplasmic HuR may regulate translation of specific mRNAs.
Attempts to modulate HuR expression and correlate this to
p27 expression have not been successful. However, we have
never been able to completely eliminate the expression of HuR
in cells (unpublished data). This indicates that HuR might not
be a limiting component of the complex. An attractive possi-
bility is that HuR binding might facilitate changes in the UTR
structure that may allow recruitment of other proteins.
We have also identified hnRNP C1/C2 as p27 59UTR bind-
ing proteins. These proteins are abundant nuclear factors that
are thought to be involved in mRNA processing (21). The C
proteins have also been implicated in translational regulation
of c-sis mRNA, which contains an internal ribosome entry site
that is induced in differentiated cells (54). Thus, these proteins
may have signal-dependent cytoplasmic roles that modulate
translation of specific mRNAs. We detect C-protein binding
activity in G2/M-arrested cells and a modified form of this
activity in cells that have induced p27 translation. The binding
of these factors to the 59UTR is dependent on the U-rich
element, providing a strong link between binding and transla-
tion. However, until we develop a cell-free cell cycle phase-
specific translation extract, not dependent on rabbit reticulo-
cyte lysate, we are unable to directly examine the role of
hnRNP C1/C2 or HuR in the translation of p27 mRNA.
Furthermore, it should be noted that the proteins that we
observed cross-linked to the 59UTR are likely to be only a
subset of proteins in a larger RNP complex, most of which may
not even contact the RNA in a manner allowing radiolabel
transfer. The exact phase of the cell cycle during which these
binding activities become cytoplasmic is unclear. We could
detect these activities in asynchronous cell extracts as well as in
extracts from G2/M cells isolated by centrifugal elutriation
(data not shown). However, the magnitude of the 59UTR bind-
ing activities in these extracts was reduced compared to that of
nocodazole-treated cells. This suggests that there may be a
very specific window of time in which these interactions could
occur. We propose that these 59UTR binding activities may
persist, perhaps due to nuclear membrane breakdown, from
G2/M through early G1. This would be an ideal time frame for
p27 mRNA to be receptive to signals that induce its transla-
tion.
Finally, with the exception of ferritin mRNA (52), there is
very little information on how UTR binding proteins can affect
induced translation. Further studies on the p27 mRNA will
provide a counterpoint to that experimental system. In con-
trast, there is extensive knowledge of proteins involved in the
basal translation machinery and how these interact to regulate
translation. Our previous work and the results presented here
identified cell cycle-regulated changes in p27 translation,
mapped sequences involved in this to the 59UTR, and begun to
identify some of the proteins which interact with these se-
quences. This should provide the foundation for developing
appropriate in vitro systems that will allow further mechanistic
analysis of induced translation and the roles of these proteins
in that process and, importantly, as a function of cell cycle
status.
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